Synopsys, Inc.
Bear Case (25th pct.)
-78.8% vs price
Base Case (Median)
-70.7% vs price
Bull Case (75th pct.)
-63.0% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $0.93 | -99.8% | High (40%) |
| PE Comparable | $111.35 | -71.4% | Medium (25%) |
| Growth Trajectory DCF | $113.98 | -70.7% | Medium (20%) |
| Graham Number | $132.02 | -66.1% | Low (10%) |
| EV/EBITDA | $156.10 | -59.9% | Medium (20%) |
| EV/FCF | $334.12 | -14.1% | Medium (20%) |
| Earnings Power Value | $53.20 | -86.3% | Medium (50%) |
Based on 7 out of 8 methods, SNPS appears overvalued at the current price of $388.99. The base case fair value of $113.98 implies 70.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.